{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:58:07Z","timestamp":1771261087276,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"crossref","award":["22\/327"],"award-info":[{"award-number":["22\/327"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"crossref","award":["22\/327"],"award-info":[{"award-number":["22\/327"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"crossref","award":["22\/327"],"award-info":[{"award-number":["22\/327"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"crossref","award":["22\/327"],"award-info":[{"award-number":["22\/327"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"crossref","award":["22\/327"],"award-info":[{"award-number":["22\/327"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"crossref","award":["22\/327"],"award-info":[{"award-number":["22\/327"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"crossref","award":["22\/327"],"award-info":[{"award-number":["22\/327"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"crossref","award":["22\/327"],"award-info":[{"award-number":["22\/327"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"crossref","award":["22\/327"],"award-info":[{"award-number":["22\/327"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-025-13233-3","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T13:16:20Z","timestamp":1756127780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["T\u016b Whakaruruhau: the evaluation of treatment outcomes for methamphetamine dependence in Aotearoa, New Zealand \u2013 study protocol for a prospective longitudinal cohort study and longitudinal qualitative study"],"prefix":"10.1186","volume":"25","author":[{"given":"David A.L","family":"Newcombe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"de Fossard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"McKetin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vili","family":"Nosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varsha","family":"Parag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Te R\u014dpu","family":"Poa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Ramalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Braden Te","family":"Ao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janie","family":"Sheridan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carina","family":"Walters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"13233_CR1","unstructured":"Ministry of Health. 2024. Annual Data Explorer 2023\/2024: New Zealand Health Survey. https:\/\/minhealthnz.shinyappsio\/nz-health-survey-2023-24-annual-data-explorer\/"},{"issue":"6","key":"13233_CR2","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1111\/add.15783","volume":"117","author":"GC Chan","year":"2022","unstructured":"Chan GC, Sun T, Lim C, Stjepanovi\u0107 D, Rutherford B, Johnson B, et al. Did the under-reporting of meth\/amphetamine use increase in a general population survey in Australia as negative media coverage increased? Addiction. 2022;117(6):1787\u201393.","journal-title":"Addiction"},{"issue":"9","key":"13233_CR3","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1177\/02698811231182012","volume":"37","author":"R Crossin","year":"2023","unstructured":"Crossin R, Cleland L, Wilkins C, Rychert M, Adamson S, Potiki T, et al. The New Zealand drug harms ranking study: a multi-criteria decision analysis. J Psychopharmacol. 2023;37(9):891\u2013903.","journal-title":"J Psychopharmacol"},{"key":"13233_CR4","unstructured":"McFadden Consultancy. Research report: the New Zealand drug harm index 2016 (2nd edn). Wellington: Ministry of Health. 2016."},{"issue":"7","key":"13233_CR5","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/j.1360-0443.2009.02564.x","volume":"104","author":"CC Cruickshank","year":"2009","unstructured":"Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Addiction. 2009;104(7):1085\u201399.","journal-title":"Addiction"},{"issue":"4","key":"13233_CR6","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1152\/physrev.00014.2018","volume":"99","author":"ND Volkow","year":"2019","unstructured":"Volkow ND, Michaelides M, Baler R. The neuroscience of drug reward and addiction. Physiol Rev. 2019;99(4):2115\u201340.","journal-title":"Physiol Rev"},{"issue":"3","key":"13233_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/09595230801923702","volume":"27","author":"S Darke","year":"2008","unstructured":"Darke S, Kaye S, McKetin R, Duflou J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev. 2008;27(3):253\u201362.","journal-title":"Drug Alcohol Rev"},{"issue":"8","key":"13233_CR8","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1111\/j.1360-0443.2007.01874.x","volume":"102","author":"S Kaye","year":"2007","unstructured":"Kaye S, McKetin R, Duflou J, Darke S. Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction. 2007;102(8):1204\u201311.","journal-title":"Addiction"},{"issue":"4","key":"13233_CR9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0736-4679(03)00031-3","volume":"24","author":"SD Turnipseed","year":"2003","unstructured":"Turnipseed SD, Richards JR, Kirk JD, Diercks DB, Amsterdam EA. Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphetamine use. J Emerg Med. 2003;24(4):369\u201373.","journal-title":"J Emerg Med"},{"key":"13233_CR10","doi-asserted-by":"crossref","unstructured":"Perez JA Jr., Arsura EL, Strategos S. Methamphetamine-related stroke: four cases. J Emerg Med. 1999;17(3):469\u201371.","DOI":"10.1016\/S0736-4679(99)00009-8"},{"issue":"3","key":"13233_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1001\/jamapsychiatry.2013.283","volume":"70","author":"R McKetin","year":"2013","unstructured":"McKetin R, Lubman DI, Baker AL, Dawe S, Ali RL. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study. JAMA Psychiatr. 2013;70(3):319\u201324.","journal-title":"JAMA Psychiatr"},{"key":"13233_CR12","unstructured":"Connell PH. Amphetamine psychosis Maudsley monographs no5. London: Oxford University Press; 1958."},{"key":"13233_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.drugalcdep.2016.01.018","volume":"161","author":"R McKetin","year":"2016","unstructured":"McKetin R, Dawe S, Burns RA, Hides L, Kavanagh DJ, Teesson M, et al. The profile of psychiatric symptoms exacerbated by methamphetamine use. Drug Alcohol Depend. 2016;161:104\u20139.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"13233_CR14","first-page":"335","volume":"71","author":"SL Simon","year":"2010","unstructured":"Simon SL, Dean AC, Cordova X, Monterosso JR, London ED. Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence. JSAD. 2010;71(3):335\u201344.","journal-title":"JSAD"},{"issue":"8","key":"13233_CR15","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.addbeh.2005.10.004","volume":"31","author":"I Sommers","year":"2006","unstructured":"Sommers I, Baskin D, Baskin-Sommers A. Methamphetamine use among young adults: health and social consequences. Addict Behav. 2006;31(8):1469\u201376.","journal-title":"Addict Behav"},{"issue":"2","key":"13233_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/add.16347","volume":"119","author":"H Sharafi","year":"2024","unstructured":"Sharafi H, Bakouni H, McAnulty C, Drouin S, Coronado-Montoya S, Bahremand A, et al. Prescription psychostimulants for the treatment of amphetamine\u2010type stimulant use disorder: a systematic review and meta\u2010analysis of randomized placebo\u2010controlled trials. Addiction. 2024;119(2):211\u201324.","journal-title":"Addiction"},{"issue":"10209","key":"13233_CR17","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/S0140-6736(19)32230-5","volume":"394","author":"M Farrell","year":"2019","unstructured":"Farrell M, Martin NK, Stockings E, B\u00f3rquez A, Cepeda JA, Degenhardt L, et al. Responding to global stimulant use: challenges and opportunities. Lancet. 2019;394(10209):1652\u201367.","journal-title":"Lancet"},{"key":"13233_CR18","doi-asserted-by":"publisher","unstructured":"Minozzi S, Saulle R, De Crescenzo F, Amato L. Psychosocial interventions for psychostimulant misuse. Cochrane Database Syst Reviews. 2016(9):CD011866. https:\/\/doi.org\/10.1002\/14651858.CD011866.pub2","DOI":"10.1002\/14651858.CD011866.pub2"},{"key":"13233_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108060","volume":"212","author":"P AshaRani","year":"2020","unstructured":"AshaRani P, Hombali A, Seow E, Ong WJ, Tan JH, Subramaniam MJD, et al. Non-pharmacological interventions for methamphetamine use disorder: a systematic review. Drug Alcohol Depend. 2020;212: 108060.","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"13233_CR20","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1111\/j.1360-0443.2012.03933.x","volume":"107","author":"R McKetin","year":"2012","unstructured":"McKetin R, Najman JM, Baker AL, Lubman DI, Dawe S, Ali R, et al. Evaluating the impact of community-based treatment options on methamphetamine use: findings from the methamphetamine treatment evaluation study (MATES). Addiction. 2012;107(11):1998\u20132008.","journal-title":"Addiction"},{"key":"13233_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.drugalcdep.2014.02.702","volume":"139","author":"M-L Brecht","year":"2014","unstructured":"Brecht M-L, Herbeck D. Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors. Drug Alcohol Depend. 2014;139:18\u201325.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"13233_CR22","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1001\/archpsyc.58.5.503","volume":"58","author":"Y-I Hser","year":"2001","unstructured":"Hser Y-I, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001;58(5):503\u20138.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"13233_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0740-5472(03)00130-2","volume":"25","author":"RL Hubbard","year":"2003","unstructured":"Hubbard RL, Craddock SG, Anderson J. Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abuse Treat. 2003;25(3):125\u201334.","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"13233_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1046\/j.1360-0443.2003.00296.x","volume":"98","author":"M Gossop","year":"2003","unstructured":"Gossop M, Marsden J, Stewart D, Kidd T. The national treatment outcome research study (NTORS): 4\u20135 year follow-up results. Addiction. 2003;98(3):291\u2013303.","journal-title":"Addiction"},{"issue":"1","key":"13233_CR25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1360-0443.2007.02029.x","volume":"103","author":"M Teesson","year":"2008","unstructured":"Teesson M, Mills K, Ross J, Darke S, Williamson A, Havard A. The impact of treatment on 3 years\u2019 outcome for heroin dependence: findings from the Australian treatment outcome study (ATOS). Addiction. 2008;103(1):80\u20138.","journal-title":"Addiction"},{"issue":"6","key":"13233_CR26","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/j.1360-0443.2004.00707.x","volume":"99","author":"RA Rawson","year":"2004","unstructured":"Rawson RA, Marinelli-Casey P, Anglin MD, Dickow A, Frazier Y, Gallagher C, et al. A multi\u2010site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction. 2004;99(6):708\u201317.","journal-title":"Addiction"},{"key":"13233_CR27","doi-asserted-by":"publisher","DOI":"10.1108\/TC-01-2016-0003","author":"J King","year":"2016","unstructured":"King J, Dow J, Stevenson B. Measuring outcomes for TC clients: higher ground drug rehabilitation trust. Therapeutic Communities: The International Journal of Therapeutic Communities. 2016. https:\/\/doi.org\/10.1108\/TC-01-2016-0003.","journal-title":"Therapeutic Communities: The International Journal of Therapeutic Communities"},{"key":"13233_CR28","unstructured":"Wilkins C, Prasad J, Wong K, Rychert M. Recent trends in illegal drug use in New Zealand, 2006\u20132014: findings from the 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014 illicit drug monitoring system (IDMS). Social and Health Outcomes Research and Evaluation, College of Health, Massey University; 2015."},{"issue":"5","key":"13233_CR29","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1046\/j.1360-0443.1995.9056072.x","volume":"90","author":"M Gossop","year":"1995","unstructured":"Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, et al. The severity of dependence scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995;90(5):607\u201314.","journal-title":"Addiction"},{"key":"13233_CR30","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al. The Mini-International Neuropsychiatric Interview (M .I .N .I): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22-33."},{"key":"13233_CR31","unstructured":"McLellan AT, Cacciola JS, Zanis D. The Addiction Severity Index- \"lite \" (ASI- \"Lite\"). Center for the Studies on Addiction, University of Pennsylvania\/Philadelphia VA Medical Center . 1997."},{"key":"13233_CR32","first-page":"100014","volume":"2","author":"A Walji","year":"2022","unstructured":"Walji A, Romano I, Levitt E, Sousa S, Rush B, MacKillop J, et al. Psychometric evaluation of the treatment entry questionnaire to assess extrinsic motivation for inpatient addiction treatment. Drug Alcohol Depend. 2022;2:100014.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"13233_CR33","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1001\/jamapsychiatry.2017.0298","volume":"74","author":"B Ustun","year":"2017","unstructured":"Ustun B, Adler LA, Rudin C, Faraone SV, Spencer TJ, Berglund P, et al. The world health organization adult attention-deficit\/hyperactivity disorder self-report screening scale for DSM-5. JAMA Psychiatr. 2017;74(5):520\u20136.","journal-title":"JAMA Psychiatr"},{"issue":"5","key":"13233_CR34","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1360-0443.1992.tb02719.x","volume":"87","author":"S Darke","year":"1992","unstructured":"Darke S, Hall W, Wodaki A, Heather N, Ward J. Development and validation of a multidimensional instrument for assessing outcome of treatment among opiate users: the opiate treatment index. Br J Addict. 1992;87(5):733\u201342.","journal-title":"Br J Addict"},{"issue":"2","key":"13233_CR35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/j.1440-1614.2000.00728.x","volume":"34","author":"A Jablensky","year":"2000","unstructured":"Jablensky A, McGrath J, Herrman H, Castle D, Gureje O, Evans M, et al. Psychotic disorders in urban areas: an overview of the study on low prevalence disorders. Aust N Z J Psychiatry. 2000;34(2):221\u201336.","journal-title":"Aust N Z J Psychiatry"},{"key":"13233_CR36","first-page":"594","volume":"12","author":"D Lukoff","year":"1986","unstructured":"Lukoff D, Nuechterlein K, Ventura J. Manual for the expanded brief psychiatric rating scale. Schizophr Bull. 1986;12:594\u2013602.","journal-title":"Schizophr Bull"},{"issue":"2","key":"13233_CR37","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1001\/archpsyc.60.2.184","volume":"60","author":"RC Kessler","year":"2003","unstructured":"Kessler RC, Barker PR, Colpe LJ, Epstein JF, Gfroerer JC, Hiripi E, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry. 2003;60(2):184\u20139.","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"13233_CR38","first-page":"839","volume":"92","author":"L Topp","year":"1997","unstructured":"Topp L, Mattick RP. Choosing a cut-off on the severity of dependence scale (SDS) for amphetamine users. Addiction. 1997;92(7):839\u201345.","journal-title":"Addiction"},{"key":"13233_CR39","unstructured":"Sobell LC, Sobell MB, Buchan G, Cleland PA, Fedoroff I, Leo GI. The reliability of the Timeline Followback method applied to drug, cigarette, and cannabis use. In30th annual meeting of the Association for Advancement of Behavior Therapy. New York. 1996."},{"key":"13233_CR40","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199711000-00002","author":"P Dolan","year":"1997","unstructured":"Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997. https:\/\/doi.org\/10.1097\/00005650-199711000-00002.","journal-title":"Med Care"},{"key":"13233_CR41","volume-title":"Wh\u0101ngaihia Te Hua o Oranga Ki \u014d Tatou Wh\u0101nau wh\u0101nui: Ko Te Tikanga o Te Whakamahinga o Hua Oranga","author":"A Mclachlan","year":"2022","unstructured":"Mclachlan A. Wh\u0101ngaihia Te Hua o Oranga Ki \u014d Tatou Wh\u0101nau wh\u0101nui: Ko Te Tikanga o Te Whakamahinga o Hua Oranga. Wellington: Te Rau Ora; 2022."},{"issue":"2","key":"13233_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0376-8716(99)00088-5","volume":"57","author":"GW Joe","year":"1999","unstructured":"Joe GW, Simpson DD, Broome KMJD. Retention and patient engagement models for different treatment modalities in DATOS. Drug Alcohol Depend. 1999;57(2):113\u201325.","journal-title":"Drug Alcohol Depend"},{"issue":"28","key":"13233_CR43","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661\u201379.","journal-title":"Stat Med"},{"key":"13233_CR44","doi-asserted-by":"publisher","DOI":"10.2307\/2095230","author":"RA Berk","year":"1983","unstructured":"Berk RA. An introduction to sample selection bias in sociological data. Am Sociol Rev. 1983. https:\/\/doi.org\/10.2307\/2095230.","journal-title":"Am Sociol Rev"},{"issue":"4","key":"13233_CR45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3109\/14659891.2014.900580","volume":"20","author":"S Ciketic","year":"2015","unstructured":"Ciketic S, Hayatbakhsh R, McKetin R, Doran CM, Najman JM. Cost-effectiveness of counselling as a treatment option for methamphetamine dependence. J Subst Use. 2015;20(4):239\u201346.","journal-title":"J Subst Use"},{"issue":"1","key":"13233_CR46","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1478-7547-11-6","volume":"11","author":"D Husereau","year":"2013","unstructured":"Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated health economic evaluation reporting standards (CHEERS) statement. Cost Eff Resource Allocation. 2013;11(1):6.","journal-title":"Cost Eff Resource Allocation"},{"issue":"5","key":"13233_CR47","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/hec.944","volume":"14","author":"A Manca","year":"2005","unstructured":"Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost\u2010effectiveness analysis: the importance of controlling for baseline utility. Health Econ. 2005;14(5):487\u201396.","journal-title":"Health Econ"},{"key":"13233_CR48","doi-asserted-by":"publisher","first-page":"160940692096579","DOI":"10.1177\/1609406920965799","volume":"19","author":"EL Tuthill","year":"2020","unstructured":"Tuthill EL, Maltby AE, DiClemente K, Pellowski JA. Longitudinal qualitative methods in health behavior and nursing research: assumptions, design, analysis and lessons learned. Int J Qual Methods. 2020;19:1609406920965799.","journal-title":"Int J Qual Methods"},{"issue":"1","key":"13233_CR49","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1471-2288-13-14","volume":"13","author":"L Calman","year":"2013","unstructured":"Calman L, Brunton L, Molassiotis A. Developing longitudinal qualitative designs: lessons learned and recommendations for health services research. BMC Med Res Methodol. 2013;13(1):14.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"13233_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-022-01732-4","volume":"22","author":"\u00c5 Audulv","year":"2022","unstructured":"Audulv \u00c5, Hall EO, Kneck \u00c5, Westergren T, Fegran L, Pedersen MK, et al. Qualitative longitudinal research in health research: a method study. BMC Med Res Methodol. 2022;22(1): 255.","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"13233_CR51","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/add.13314","volume":"111","author":"J Neale","year":"2016","unstructured":"Neale J. Iterative categorization (IC): a systematic technique for analysing qualitative data. Addiction. 2016;111(6):1096\u2013106.","journal-title":"Addiction"},{"issue":"9596","key":"13233_CR52","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E Von Elm","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137.","journal-title":"Lancet"},{"key":"13233_CR53","unstructured":"International Committee of Medical Journal Editors. Defining the Role of Authors and Contributors: International Committee of Medical Journal Editors; [cited 2025 12\/03\/2025]. Available from: https:\/\/www.icmje.org\/recommendations\/browse\/roles-and-responsibilities\/defining-the-role-of-authors-and-contributors.html"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13233-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-13233-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13233-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T14:00:11Z","timestamp":1757426411000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-025-13233-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13233"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-13233-3","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"23 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This programme of work was approved by the New Zealand Central Health and Disability Ethics Committees (reference: 2023 EP 15148). Ethics approval for any amendments to the study protocol will be sought. Maintenance of confidentiality and compliance with NZ\u2019s Privacy Act will be emphasised to all study participants. Participation in the study will be entirely voluntary. Written consent will be obtained from all participants for both studies prior to enrolling in the study. All data collected for Study 1 will be entered, stored and backed-up in a secure manner via an internet data management system. Qualitative data from study 2 will be initially stored as audio files on a secure password protected site prior to transcription. Transcription will be undertaken by a local transcription company that is ISO9001 and ISO27001 accredited. The transcription company will be required to sign and adhere to a data management agreement. Transcription will be undertaken by transcribers based in New Zealand. Both the recoding and transcription will be securely stored until after the study has finished to allow researchers to check that the transcription was accurate. Once the researchers have finished the analysis the audio recordings will be destroyed. If any participants suffer harm from study participation, they will be eligible for compensation via their private health or life insurance, or via NZ\u2019s Accident Compensation Corporation (ACC) scheme.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No identifiable individual participant data (names or other personal identifiers) are contained in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1131"}}